Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease

Congenital metabolic diseases are a group of hereditary disorders caused by the deficiency of a single specific enzyme activity. Without appropriate therapy, affected patients suffer severe neurologic disability and eventual death. The current mainstays of management attempt to slow disease progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Chika, Grubbs, Brendan H., Ishige, Mika, Ogawa, Erika, Morioka, Ichiro, Hayakawa, Satoshi, Miki, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133340/
https://www.ncbi.nlm.nih.gov/pubmed/33547875
http://dx.doi.org/10.1002/sctm.20-0225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133340/
https://www.ncbi.nlm.nih.gov/pubmed/33547875
http://dx.doi.org/10.1002/sctm.20-0225

Ejemplares similares